Treatment Preferences, Monthly Injection is the Preferred Frequency of Administration in the Treatment of Moderate to Severe Atopic Dermatitis: Results from a Real-World Survey in the United States

Main Article Content

William Malatestinic
US, Lilly

April Armstrong
Bob Geng
Peter Lio
Melodie Young
Tomas Chao
Evangeline Pierce
Zach Dawson

Keywords

atopic dermatitis, q2 week dosing, q4 week dosing, patient preferences, physician preferences

Abstract

None

References

1. Neha Puar, Raj Chovatiya, Amy S. Paller, New treatments in atopic dermatitis, Annals of Allergy, Asthma & Immunology, Volume 126, Issue 1, 2021, Pages 21-31, ISSN 1081-1206, https://doi.org/10.1016/j.anai.2020.08.016.

Article Sidebar

PDF
Published
Jan 13, 2025
DOI https://doi.org/10.25251/skin.9.supp.513

Article Details

How to Cite
[1]
Malatestinic, W., Armstrong, A. , Geng, B., Lio, P., Young, M., Chao, T., Pierce, E. and Dawson, Z. 2025. Treatment Preferences, Monthly Injection is the Preferred Frequency of Administration in the Treatment of Moderate to Severe Atopic Dermatitis: Results from a Real-World Survey in the United States . SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s513. DOI:https://doi.org/10.25251/skin.9.supp.513.
Issue
Vol. 9 No. 1 (2025): January 2025 Issue
Section
Atopic Dermatitis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>